Roche

Roche melanoma drug wins European green light
Reuters
Fri, 12/16/11 - 10:30 am
Roche
melanoma
Europe
EMA
Zelboraf
2012 Preview: Cancer Immunotherapy Catalysts
Seeking Alpha
Thu, 12/15/11 - 12:08 pm
cancer
Antigenics
Amgen
Bristol-Myers Squibb
Celgene
Dendreon
Generex
Merck KGaA
GSK
Idera Pharmaceuticals
NewLink Genetics
Novartis
Roche
Oncothyreon
Transgene
Vical
Fat-Burning Roche Medicine Stops Diabetes in Mice Study, Researchers Say
Bloomberg
Wed, 12/14/11 - 06:44 pm
Roche
diabetes
FGF21
9 Biotech Companies With FDA Approval Decision Dates In Q1 2012
Seeking Alpha
Mon, 12/12/11 - 11:14 am
FDA
Fentanyl SL
INSYS Therapeutics
Dapagliflozin
Bristol-Myers Squibb
Prochieve
Columbia Laboratories
Discovery Labs
Surfaxin
NeurogesX
Qutenza
Curis
Roche
vismodegib
Chelsea Therapeutics
Northera
ONYX Pharmaceuticals
Carfilzomib
Roche, Labcyte to team on PCR
Thu, 12/8/11 - 10:20 pm
Roche
PCR
Hungry biotechs make better partners for Big Pharma
Fierce Biotech
Thu, 12/8/11 - 11:58 am
biotech
Big Pharma
Roche
Zelboraf
vismodegib
New Setback for Avastin as Breast Cancer Treatment
NY Times, NY
Thu, 12/8/11 - 11:39 am
breast cancer
Avastin
Roche
Genentech
Roche and Pfizer launch pharma's first official Google+ pages
PM Live
Tue, 12/6/11 - 11:40 am
Roche
Pfizer
social media
Google+
Regeneron Drops as Eye Drug Shown Similar to Roche's Lucentis
Bloomberg Businessweek
Mon, 12/5/11 - 12:28 pm
Roche
Lucentis
Regeneron
Eyela
wet-AMD
Roche Pays $20M To Settle Whistleblower Lawsuit
Pharmalot
Fri, 12/2/11 - 11:20 am
Roche
whistleblower lawsuits
Rituxan
Medicare
Medicaid
CEO: Roche would consider more money-back deals
Fierce Pharma
Thu, 12/1/11 - 12:16 pm
Avastin
Roche
Severin Schwan
Winners and Losers of Roche's Avastin Woes
Motley Fool
Tue, 11/29/11 - 06:48 pm
Roche
Avastin
breast cancer
Merck
GSK
Bristol-Myers Squibb
Eli Lilly
Teva Pharmaceuticals
Dr Reddy's
Watson
Seattle Genetics
Joining FDA, Canada pulls Avastin's breast cancer indication
Fierce Pharma
Tue, 11/29/11 - 01:40 pm
Canada
Avastin
breast cancer
Roche
Roche, PTC strike potential $490M deal for genetic disease program
Fierce Biotech
Tue, 11/29/11 - 10:22 am
Roche
PTC Therapeutics
spinal muscular atrophy
22 Hot Drugs Facing FDA Approval in 2012
TheStreet.com
Tue, 11/29/11 - 09:09 am
Amarin
AMR101
Ironwood
linaclotide
Merck
Ariad
ridaforolimus
Vivus
Qnexa
Avanafil
Amgen
Xgeva
Cell Therapeutics
pixantrone
Kalydeco
Vertex
ONYX Pharmaceuticals
Carfilzomib
Pfizer
Bristol-Myers Squibb
Eliquis
Chelsea Therapeutics
Northera
Levadex
MAP Pharmaceuticals
Roche
Curis
vismodegib
Biogen Idec
Elan
Tysabri
Amylin
Bydureon
Dapagliflozin
Uplypso
Protalix BioTherapeutics
Teva Pharmaceuticals
BioSante
Bio-T-Gel
Corlux
Corcept Therapeutics
Discovery Labs
Surfaxin
Pushing Onwards With CETP Inhibition: What Big-Time Drug Development Is All About
Seeking Alpha
Sun, 11/20/11 - 12:14 pm
CETP inhibitors
Merck
Roche
Eli Lilly
Anacetrapib
dalcetrapib
evacetrapib
F.D.A. Revokes Approval of Avastin as Breast Cancer Drug
NY Times, NY
Fri, 11/18/11 - 11:51 am
FDA
Avastin
breast cancer
Roche
Genentech
No new cost-cutting, Roche chairman pledges
Fierce Pharma
Mon, 11/14/11 - 12:24 pm
Roche
Franz Humer
FDA gives priority to Roche skin cancer drug vismodegib
Pharma Times, UK
Wed, 11/9/11 - 12:07 pm
Roche
vismodegib
FDA
skin cancer
basal cell carcinoma
hedgehog pathway inhibitor
Study: Deal terms getting richer as pharmas stockpile antibody tech
Fierce Biotech
Tue, 11/8/11 - 11:06 am
antibodies
autoimmune disease
CNS
Roche
AstraZeneca
Bristol-Myers Squibb
Novartis
Pfizer
Merck
mAb

Pages